Abbvie
Latest Stories
med--fda-hepatitis_c_drug_41947.jpg
This photo provided by AbbVie shows the drug Mavyret. On Thursday, Aug. 3, 2017, the Food and Drug Administration approved Mavyret to treat all forms of hepatitis C. The drug works in as little as eight weeks and is for patients without significant cirrhosis who haven't been treated previously for the liver-destroying virus, plus patients who were not cured by a prior treatment. (Richard Mack/Courtesy of AbbVie via AP)
drug_safety_40418.jpg
FILE - This Friday, July 18, 2014 file photo shows AbbVie's drug Humira in Houston. Almost one-third of new drugs approved by FDA from 2001-2010, including Humira, ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis suggests. Results were published Tuesday, May 9, 2017, in the Journal of the American Medical Association. (AP Photo/David J. Phillip, File)
